Generation of New Protein Kinase Inhibitors Utilizing Cytochrome P450 Mutant Enzymes for Indigoid Synthesis
- 4 May 2004
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 47 (12) , 3236-3241
Abstract
Indigoids, a class of bis-indoles, represent a promising protein kinase inhibitor scaffold. Oxidation of indole by cytochrome P450 (P450) has been shown to generate species (indoxyl, isatin) that couple to yield indigo and indirubin. Escherichia coli-expressed human P450 2A6 mutants isolated from a randomized library were incubated with 27 substituted indole derivatives. Extracts of the cultures were screened for inhibition of human cyclin-dependent kinases (CDK)-1 and -5 and glycogen synthase kinase-3 (GSK3). The extracts from cultures incubated with 5-methoxyindole were the most inhibitory. High-performance liquid chromatography (HPLC) separation yielded a mixture of seven colored indigoids. These indigoids included indigo, indirubin, the di(5-methoxy) derivatives of indigo and indirubin, and both of the possible mono 5-methoxy derivatives of indirubin, which were all identified by visible, mass, and NMR spectra. Cultures with 5-methylindole added to the media also yielded inhibitory material, and 5- and 5‘-methylindirubin were characterized. The most inhibitory of these indigoids were the monosubstituted indirubins and 5,5‘-dimethoxyindirubin, which was ≥10× more active than indirubin. Thus, the overall approach involves the use of a library of randomized enzyme mutants to activate component moieties of a desired set of larger molecules, thus yielding a library of drug candidates that can be screened and characterized. The general strategy may have additional applications.Keywords
This publication has 23 references indexed in Scilit:
- Aspartate Aminotransferase Generates Proagonists of the Aryl Hydrocarbon ReceptorMolecular Pharmacology, 2003
- Putting nature back into drug discoveryNature Biotechnology, 2003
- Activation of the Aryl Hydrocarbon Receptor by Structurally Diverse Exogenous and Endogenous ChemicalsAnnual Review of Pharmacology and Toxicology, 2003
- Anti-mitotic properties of indirubin-3′-monoxime, a CDK/GSK-3 inhibitor: induction of endoreplication following prophase arrestOncogene, 2001
- Indirubins Inhibit Glycogen Synthase Kinase-3β and CDK5/P25, Two Protein Kinases Involved in Abnormal Tau Phosphorylation in Alzheimer's DiseaseJournal of Biological Chemistry, 2001
- Drug metabolism by Escherichia coli expressing human cytochromes P450Nature Biotechnology, 1997
- Biotechnology, bioremediation, and blue genesNature Biotechnology, 1997
- Analysis of tissue residues and comparative metabolism of virginiamycin in rats, turkeys, and cattleJournal of Agricultural and Food Chemistry, 1987
- Expression of Naphthalene Oxidation Genes in Escherichia coli Results in the Biosynthesis of IndigoScience, 1983
- Ueber das Diimidophtaleïn des PhenolsEuropean Journal of Inorganic Chemistry, 1878